ArticleOncotarget2017

GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.

Yung-Kuan Tsou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.